Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

AMMAR M YOUSIF

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1457745531
CMS profile
5697768
Location
LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$4,214.79

195 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,931.95 191
Long term medical supply or device loan $166.66 2
Education $116.18 2

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $336.59 19
NOVARTIS PHARMACEUTICALS CORPORATION $261.55 10
Eisai Inc. $240.86 12
Celgene Corporation $232.38 14
Merck Sharp & Dohme LLC $211.01 9
PFIZER INC. $183.06 14
Amgen Inc. $181.56 10
Astellas Pharma US Inc $178.00 7
Janssen Biotech, Inc. $171.45 7
EMD Serono, Inc. $168.17 9
MENARINI SILICON BIOSYSTEMS, INC. $166.13 1
Alexion Pharmaceuticals, Inc. $160.08 8
BeiGene USA, Inc. $142.42 6
AstraZeneca Pharmaceuticals LP $132.77 5
JAZZ PHARMACEUTICALS INC. $85.87 5
Boehringer Ingelheim Pharmaceuticals, Inc. $85.07 3
E.R. Squibb & Sons, L.L.C. $83.33 4
Genmab U.S., Inc. $82.52 3
Pharmacyclics LLC, An AbbVie Company $78.34 3
Incyte Corporation $75.28 3
Sumitomo Pharma America, Inc. $60.88 3
SOBI, INC $56.51 2
Regeneron Healthcare Solutions, Inc. $52.39 2
SERVIER PHARMACEUTICALS LLC $47.76 2
CTI BioPharma Corp. $46.94 2
Exelixis Inc. $46.49 1
Bayer Healthcare Pharmaceuticals Inc. $45.18 2
Seagen Inc. $40.69 2
Stemline Therapeutics Inc. $38.52 2
Puma Biotechnology, Inc. $37.60 2
Takeda Pharmaceuticals U.S.A., Inc. $35.91 2
TerSera Therapeutics LLC $33.96 1
Ipsen Biopharmaceuticals, Inc $33.88 2
Mirati Therapeutics, Inc. $33.83 2
Fresenius Kabi USA, LLC $33.12 1
Genentech USA, Inc. $32.64 2
TAIHO ONCOLOGY, INC. $29.11 1
Daiichi Sankyo Inc. $28.18 1
Alnylam Pharmaceuticals Inc. $25.75 1
Gilead Sciences, Inc. $24.06 1
AbbVie Inc. $23.65 1
Pharmacosmos Therapeutics Inc. $22.92 1
GENZYME CORPORATION $22.85 1
PharmaEssentia USA Corporation $21.72 1
G1 Therapeutics, Inc. $20.74 1
AVEO Pharmaceuticals, Inc. $18.66 1
Coherus Biosciences Inc. $15.30 1
Organon LLC $14.98 1
Lilly USA, LLC $14.13 1

Page 4 of 4; records 151–195 of 195 matching records. This page contains 45 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

AMMAR M YOUSIF

NPI 1457745531 · CMS profile ID 5697768

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–195 of 195 matching records. This page contains 45 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1457745531?year=2023&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
AMMAR M YOUSIF, NPI 1457745531, CMS profile ID 5697768. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–195 of 195 matching records. This page contains 45 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1457745531?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). AMMAR M YOUSIF, NPI 1457745531, CMS profile ID 5697768. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–195 of 195 matching records. This page contains 45 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1457745531?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
AMMAR M YOUSIF, NPI 1457745531, CMS profile ID 5697768, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–195 of 195 matching records. This page contains 45 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1457745531?year=2023&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

195 matching records · $4,214.79 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 195 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–195 of 195.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sumitomo Pharma America, Inc. $27.5303/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030713713 CMS
Celgene Corporation $2.6703/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015515637 CMS
Amgen Inc. $17.2603/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020532249 CMS
E.R. Squibb & Sons, L.L.C. $19.9503/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015515641 CMS
Astellas Pharma US Inc $15.5503/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033970543 CMS
Astellas Pharma US Inc $2.9603/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033972277 CMS
E.R. Squibb & Sons, L.L.C. $21.3903/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015515633 CMS
Alexion Pharmaceuticals, Inc. $16.8603/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016998315 CMS
Alexion Pharmaceuticals, Inc. $35.2403/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017055755 CMS
Eisai Inc. $19.5503/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023301025 CMS
Mirati Therapeutics, Inc. $16.0902/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058006939 CMS
Gilead Sciences, Inc. $24.0602/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025671239 CMS
Amgen Inc. $23.8102/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019796423 CMS
BeiGene USA, Inc. $32.8602/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051179057 CMS
Eisai Inc. $19.2902/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023301039 CMS
Eisai Inc. $22.1602/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023301041 CMS
Pharmacyclics LLC, An AbbVie Company $29.4302/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998298331 CMS
Incyte Corporation $28.3402/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044913913 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $83.3302/15/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993431929 CMS
Seagen Inc. $19.7702/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995797125 CMS
EMD Serono, Inc. $3.1302/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032326500 CMS
EMD Serono, Inc. $18.4502/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032327959 CMS
Eisai Inc. $22.3602/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023301029 CMS
AstraZeneca Pharmaceuticals LP $37.9602/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015823875 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.4802/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996409699 CMS
Amgen Inc. $10.7002/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020532253 CMS
Mirati Therapeutics, Inc. $17.7402/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058006935 CMS
Celgene Corporation $10.3802/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015515577 CMS
Novartis Pharmaceuticals Corporation $7.1502/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993337575 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.8301/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000503769 CMS
Alexion Pharmaceuticals, Inc. $14.8101/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017053121 CMS
Eisai Inc. $18.6601/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023301027 CMS
Eisai Inc. $17.7801/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023301031 CMS
Janssen Biotech, Inc. $29.4301/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351961 CMS
Celgene Corporation $14.8301/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015515581 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $83.3301/14/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993431927 CMS
Amgen Inc. $18.2101/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020532251 CMS
Astellas Pharma US Inc $18.3401/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033865051 CMS
AstraZeneca Pharmaceuticals LP $16.2801/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014321937 CMS
Novartis Pharmaceuticals Corporation $9.6801/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993337573 CMS
Janssen Biotech, Inc. $17.9301/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988351951 CMS
GlaxoSmithKline, LLC. $17.4101/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001711997 CMS
Merck Sharp & Dohme LLC $23.9801/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048846243 CMS
Amgen Inc. $21.4601/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019796419 CMS
BeiGene USA, Inc. $28.8301/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051179055 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $633.83 24
PY2020 $140.85 7
PY2021 $2,138.46 77
PY2022 $5,343.00 260
PY2023 $4,214.79 195
PY2024 $4,626.15 217
PY2025 $5,139.74 207

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.